Document is current
Any future updates will be listed below
-
Authors
Nakashima, Masayuki https://orcid.org/0000-0001-8551-2803
Ide, Kazuki https://orcid.org/0000-0001-6377-1361
Kawakami, Koji https://orcid.org/0000-0002-7477-4071
- License Information
-
More Information
Article History
First Online: 15 May 2019
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript.
: Koji Kawakami receives honoraria from Shin Nippon Biomedical Laboratories, LTD.; research funds from: Olympus Corporation, Sumitomo Dainippon Pharma Co., Ltd., Bayer Yakuhin Ltd., Stella Pharma Corporation, Novartis Pharma K.K., CMIC Co., Ltd., Amgen Astellas BioPharma K.K., Suntory Beverage & Food Ltd., Medical Platform Co., Ltd.; and holds stocks of: School Health Record Center Co., Ltd. and Real World Data, Co., Ltd. There are no patent products under development or marketed products to declare, relevant to those companies. Masayuki Nakashima and Kazuki Ide declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
